jueves, 19 abril, 2018

HIPEC improves survival in stage III epithelial ovarian cancer

The Lancet Oncology Fecha de publicación: 25 January 2018 DOI: https://doi.org/10.1016/S1470-2045(18)30065-2 Autores: Robert Stirrups Background: The addition of hyperthermic intraperitoneal chemotherapy (HIPEC) to interval cytoreductive surgery improves outcomes in...

Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted...

The Lancet Oncology Fecha de publicación: 12 February 2018 DOI: https://doi.org/10.1016/S1470-2045(18)30078-0 Autores: Jennifer L McQuade, Carrie R Daniel, Kenneth R Hess, Carmen Mak, Daniel Y Wang, Rajat R Rai, John...

Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted...

THE LANCET ONCOLOGY Fecha de publicación: Marzo 2018 DOI: https://doi.org/10.1016/S1470-2045(18)30078-0 Autores: Jennifer L McQuade, Carrie R Daniel, Kenneth R Hess, Carmen Mak, Daniel Y Wang, Rajat R Rai, John...

Chromatin organisation and cancer prognosis: a pan-cancer study

THE LANCET ONCOLOGY Fecha de publicación: Marzo 2018 DOI: https://doi.org/10.1016/S1470-2045(17)30899-9 Autores: Andreas Kleppe, Fritz Albregtsen, Ljiljana Vlatkovic, Manohar Pradhan, Birgitte Nielsen, Tarjei S Hveem, Hanne A Askautrud, Gunnar B...
PORTADA-THELANCETONCOLOGY-Febrero2018

Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study

The Lancet Oncology Published: 11 January 2018 DOI: https://doi.org/10.1016/S1470-2045(17)30891-4 Ellen R Copson, PhD*, Tom C Maishman, MSc*, Will J Tapper, PhD, Ramsey I Cutress, PhD, Stephanie Greville-Heygate, MB,...

Neoadjuvant chemotherapy in breast cancer: more than just downsizing

The Lancet Oncology Published:  11 December 2017 DOI: http://dx.doi.org/10.1016/S1470-2045(17)30914-2 Marloes G M Derks, Cornelis J H van de Velde Background: The Early Breast Cancer Trialists' Collaborative Group (EBCTCG) has...

Tumour infiltrating lymphocytes in breast cancer: increasing clinical relevance

The Lancet Oncology Published:  07 December 2017 DOI: http://dx.doi.org/10.1016/S1470-2045(17)30905-1 Roberto Salgado, Sherene Loi Background: The immune microenvironment is now recognised as crucial in the treatment of cancer. The tumour immune...
lancet-oncology-diciembre2017

Incomplete excision of cervical precancer as a predictor of treatment failure: a systematic review...

The Lancet Oncology Published: 07 November 2017 DOI: http://dx.doi.org/10.1016/S1470-2045(17)30700-3 Marc Arbyn, Charles W E Redman, MD, Freija Verdoodt, PhD, Maria Kyrgiou, PhD, Menelaos Tzafetas, MD, Sadaf Ghaem-Maghami, PhD, Prof Karl-Ulrich Petry, PhD, Simon Leeson, MD, Christine Bergeron,...